These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 32689578)

  • 21. Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical Trial.
    Khatri P; Kleindorfer DO; Devlin T; Sawyer RN; Starr M; Mejilla J; Broderick J; Chatterjee A; Jauch EC; Levine SR; Romano JG; Saver JL; Vagal A; Purdon B; Devenport J; Pavlov A; Yeatts SD;
    JAMA; 2018 Jul; 320(2):156-166. PubMed ID: 29998337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic potential of platelet glycoprotein IIb/IIIa receptor antagonists in the management of ischemic stroke.
    Lapchak PA; Araujo DM
    Am J Cardiovasc Drugs; 2003; 3(2):87-94. PubMed ID: 14727935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of tirofiban combined with endovascular treatment in acute ischaemic stroke.
    Pan X; Zheng D; Zheng Y; Chan PWL; Lin Y; Zou J; Zhou J; Yang J
    Eur J Neurol; 2019 Aug; 26(8):1105-1110. PubMed ID: 30793464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preclusion of ischemic stroke patients from intravenous tissue plasminogen activator treatment for mild symptoms should not be based on low National Institutes of Health Stroke Scale Scores.
    Wendt M; Tütüncü S; Fiebach JB; Scheitz JF; Audebert HJ; Nolte CH
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):550-3. PubMed ID: 23433783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bleeding risk of tirofiban, a nonpeptide GPIIb/IIIa platelet receptor antagonist in progressive stroke: an open pilot study.
    Junghans U; Seitz RJ; Aulich A; Freund HJ; Siebler M
    Cerebrovasc Dis; 2001; 12(4):308-12. PubMed ID: 11721100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of tirofiban in treating patients with progressive ischemic stroke.
    Du N; Wang LX; Liu YL; Yin XL; Zhao JS; Yang L
    Eur Rev Med Pharmacol Sci; 2022 Mar; 26(6):2098-2105. PubMed ID: 35363359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between tirofiban monotherapy and efficacy and safety in acute ischemic stroke.
    Tao C; Zhu Y; Zhang C; Song J; Liu T; Yuan X; Luo W; Chen C; Liu D; Zhu Y; Liu J; Hu W
    BMC Neurol; 2021 Jun; 21(1):237. PubMed ID: 34167477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety of tirofiban and dual antiplatelet therapy in treating intracranial aneurysms.
    Samaniego EA; Gibson E; Nakagawa D; Ortega-Gutierrez S; Zanaty M; Roa JA; Jabbour P; Hasan DM
    Stroke Vasc Neurol; 2019 Mar; 4(1):36-42. PubMed ID: 31105977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraarterial Versus Intravenous Tirofiban as an Adjunct to Endovascular Thrombectomy for Acute Ischemic Stroke.
    Yang J; Wu Y; Gao X; Bivard A; Levi CR; Parsons MW; Lin L;
    Stroke; 2020 Oct; 51(10):2925-2933. PubMed ID: 32933416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of In-Hospital Bleeding and Cardiovascular Events with High-Dose Bolus Tirofiban and Shortened Infusion to Short-Duration Eptifibatide as Adjunctive Therapy for Percutaneous Coronary Intervention.
    Anderson GL; Osborn JL; Nei SD; Bell MR; Barsness GW; Mara KC; Ou NN
    Am J Cardiol; 2019 Jan; 123(1):44-49. PubMed ID: 30539747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A safety and feasibility report of combined direct thrombin and GP IIb/IIIa inhibition with bivalirudin and tirofiban in peripheral vascular disease intervention: treating critical limb ischemia like acute coronary syndrome.
    Allie DE; Hebert CJ; Lirtzman MD; Wyatt CH; Keller VA; Khan MH; Khan MA; Fail PS; Vivekananthan K; Allie SE; Mitran EV; Chaisson G; Stagg SJ; Allie AA; McElderry MW; Barker EA; Walker CM
    J Invasive Cardiol; 2005 Aug; 17(8):427-32. PubMed ID: 16079449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and Efficacy of Tirofiban in Acute Ischemic Stroke Patients Receiving Endovascular Treatment: A Meta-Analysis.
    Fu Z; Xu C; Liu X; Wang Z; Gao L
    Cerebrovasc Dis; 2020; 49(4):442-450. PubMed ID: 32731250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute Stenting and Concomitant Tirofiban Administration for the Endovascular Treatment of Acute Ischemic Stroke Related to Intracranial Artery Dissections: A Single Center Experience and Systematic Review of the Literature.
    Bernava G; Meling TR; Rosi A; Hofmeister J; Yilmaz H; Brina O; Reymond P; Muster M; Corniola MV; Carrera E; Lovblad KO; Kulcsar Z; Machi P
    J Stroke Cerebrovasc Dis; 2021 Aug; 30(8):105891. PubMed ID: 34090173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual antiplatelet therapy versus intravenous tissue plasminogen activator with acute minor ischemic stroke: A systematic review and meta-analysis of safety and efficacy.
    Abbas A; Hamad AA; El Din Moawad MH; Ewis DK; Youssef RA; Hamouda H; Hassan MA; Aladawi M; Elfil M; Meshref M; Al-Mufti F
    J Stroke Cerebrovasc Dis; 2024 Jul; 33(7):107704. PubMed ID: 38561167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LOAD: a pilot study of the safety of loading of aspirin and clopidogrel in acute ischemic stroke and transient ischemic attack.
    Meyer DM; Albright KC; Allison TA; Grotta JC
    J Stroke Cerebrovasc Dis; 2008; 17(1):26-9. PubMed ID: 18190818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
    Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
    Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment with Clopidogrel Prior to Acute Non-Cardioembolic Ischemic Stroke Attenuates Stroke Severity.
    Tziomalos K; Giampatzis V; Bouziana SD; Spanou M; Kostaki S; Papadopoulou M; Angelopoulou SM; Tsopozidi M; Savopoulos C; Hatzitolios AI
    Cerebrovasc Dis; 2016; 41(5-6):226-32. PubMed ID: 26795462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Former antiplatelet drug administration and consequences of intravenous thrombolysis in acute ischemic stroke.
    Khazaei M; Davoodian A; Taheri M; Ghafouri-Fard S
    Hum Antibodies; 2020; 28(1):53-56. PubMed ID: 31356199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Application of Tirofiban in the Endovascular Treatment of Acute Ischemic Stroke: A Meta-Analysis.
    Tang L; Tang X; Yang Q
    Cerebrovasc Dis; 2021; 50(2):121-131. PubMed ID: 33401276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of tirofiban in preventing neurological deterioration in acute ischemic stroke (TREND): Protocol for an investigator-initiated, multicenter, prospective, randomized, open-label, masked endpoint trial.
    Wang J; Li S; Li C; Wu C; Song H; Ma Q; Ji X; Zhao W;
    Brain Circ; 2024; 10(2):168-173. PubMed ID: 39036300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.